Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit

BACKGROUND: The treatment effect in survival analysis is commonly quantified as the hazard ratio, and tested statistically using the standard log-rank test. Modern anticancer immunotherapies are successful in a proportion of patients who remain alive even after a long-term follow-up. This new phenom...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Natl Cancer Inst
Main Authors: Péron, Julien, Lambert, Alexandre, Munier, Stephane, Ozenne, Brice, Giai, Joris, Roy, Pascal, Dalle, Stéphane, Machingura, Abigirl, Maucort-Boulch, Delphine, Buyse, Marc
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6855951/
https://ncbi.nlm.nih.gov/pubmed/30838402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djz030
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki